Supporting Information
| Supporting Information File 1: NMR and MS spectra of myxocoumarin A (7) and B (9). In-depth discussion and analysis of chemical shifts for the verification of the structure of 9. | ||
| Format: PDF | Size: 709.3 KB | Download |
Cite the Following Article
The myxocoumarins A and B from Stigmatella aurantiaca strain MYX-030
Tobias A. M. Gulder, Snežana Neff, Traugott Schüz, Tammo Winkler, René Gees and Bettina Böhlendorf
Beilstein J. Org. Chem. 2013, 9, 2579–2585.
https://doi.org/10.3762/bjoc.9.293
How to Cite
Gulder, T. A. M.; Neff, S.; Schüz, T.; Winkler, T.; Gees, R.; Böhlendorf, B. Beilstein J. Org. Chem. 2013, 9, 2579–2585. doi:10.3762/bjoc.9.293
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Behnsen, A.; Hertrampf, G.; Vojnović, S.; Nikodinović-Runić, J.; Gulder, T. A. M. Synthesis and antibiotic potential of myxocoumarin-inspired chromene dione analogs. RSC advances 2024, 14, 35215–35219. doi:10.1039/d4ra05941g
- Hertrampf, G.; Vojnovic, S.; Müller, J. I.; Merten, C.; Nikodinovic-Runic, J.; Gulder, T. A. M. Synthesis, Stereochemical Determination, and Antimicrobial Evaluation of Myxocoumarin A. The Journal of organic chemistry 2023, 88, 14184–14188. doi:10.1021/acs.joc.3c01285
- Zhang, C.-W.; Zhong, X.-J.; Zhao, Y.-S.; Rajoka, M. S. R.; Hashmi, M. H.; Zhai, P.; Song, X. Antifungal natural products and their derivatives: A review of their activity and mechanism of actions. Pharmacological Research - Modern Chinese Medicine 2023, 7, 100262. doi:10.1016/j.prmcm.2023.100262
- Saggu, S. K.; Nath, A.; Kumar, S. Myxobacteria: biology and bioactive secondary metabolites. Research in microbiology 2023, 174, 104079. doi:10.1016/j.resmic.2023.104079
- Hertrampf, G.; Kusserow, K.; Vojnovic, S.; Pavic, A.; Müller, J. I.; Nikodinovic-Runic, J.; Gulder, T. A. M. Strong Antibiotic Activity of the Myxocoumarin Scaffold in vitro and in vivo. Chemistry (Weinheim an der Bergstrasse, Germany) 2022, 28, e202200394. doi:10.1002/chem.202200394
- Gupta, S.; Li, D.; Ostrov, D. A.; Nguyen, C. Q. Epitope Mapping of Pathogenic Autoantigens on Sjögren's Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques. Journal of clinical medicine 2022, 11, 1690. doi:10.3390/jcm11061690
- Bhat, M. A.; Mishra, A. K.; Bhat, M. A.; Banday, M. I.; Bashir, O.; Rather, I. A.; Rahman, S.; Shah, A. A.; Jan, A. T. Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study. Pharmaceutics 2021, 13, 1265. doi:10.3390/pharmaceutics13081265
- Bader, C. D.; Panter, F.; Müller, R. In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites. Biotechnology advances 2019, 39, 107480. doi:10.1016/j.biotechadv.2019.107480
- Müller, J. I.; Kusserow, K.; Hertrampf, G.; Pavic, A.; Nikodinovic-Runic, J.; Gulder, T. A. M. Synthesis and initial biological evaluation of myxocoumarin B. Organic & biomolecular chemistry 2019, 17, 1966–1969. doi:10.1039/c8ob02273a
- Dehhaghi, M.; Mohammadipanah, F.; Guillemin, G. J. Myxobacterial natural products: An under-valued source of products for drug discovery for neurological disorders. Neurotoxicology 2018, 66, 195–203. doi:10.1016/j.neuro.2018.02.017
- Masschelein, J.; Jenner, M.; Challis, G. L. Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights. Natural product reports 2017, 34, 712–783. doi:10.1039/c7np00010c
- Herrmann, J.; Fayad, A. A.; Müller, R. Natural products from myxobacteria: novel metabolites and bioactivities. Natural product reports 2016, 34, 135–160. doi:10.1039/c6np00106h
- Schäberle, T. F. Biosynthesis of α-pyrones. Beilstein journal of organic chemistry 2016, 12, 571–588. doi:10.3762/bjoc.12.56
